Catalyst Wire Dossier Catalyst Wire Dossier

MVA-BN IMVAMUNE Smallpox Vaccine

Modified Vaccinia Ankara-based smallpox vaccine · Bavarian Nordic
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MVA-BN IMVAMUNE Smallpox Vaccine, covering 2019-01-09 to 2019-01-09. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II Study on Immunogenicity and Safety of MVA-BN® (IMVAMUNE™) Smallpox Vaccine in Subjects With Atopic Dermatitis [Phase 2]

See pricing